Palvella Therapeutics, Inc. (PVLA)
150.56
-3.76
(-2.44%)
USD |
NASDAQ |
Sep 18, 16:00
150.68
+0.12
(+0.08%)
After-Hours: 20:00
Palvella Therapeutics Shareholders Equity (Quarterly) : 216.87M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 216.87M |
| March 31, 2026 | 232.31M |
| December 31, 2025 | 27.98M |
| September 30, 2025 | 38.68M |
| June 30, 2025 | 47.78M |
| March 31, 2025 | 55.58M |
| September 30, 2024 | 16.27M |
| June 30, 2024 | 18.70M |
| March 31, 2024 | 21.96M |
| December 31, 2023 | 26.76M |
| September 30, 2023 | 30.51M |
| June 30, 2023 | 40.50M |
| March 31, 2023 | 15.46M |
| December 31, 2022 | 27.93M |
| September 30, 2022 | 35.77M |
| June 30, 2022 | 44.36M |
| March 31, 2022 | 53.45M |
| December 31, 2021 | 50.76M |
| September 30, 2021 | 55.67M |
| June 30, 2021 | 46.72M |
| March 31, 2021 | 38.24M |
| December 31, 2020 | 31.03M |
| September 30, 2020 | 43.69M |
| June 30, 2020 | 46.67M |
| March 31, 2020 | 49.81M |
| Date | Value |
|---|---|
| December 31, 2019 | 51.35M |
| September 30, 2019 | 20.64M |
| June 30, 2019 | 19.48M |
| March 31, 2019 | 30.16M |
| December 31, 2018 | 39.94M |
| September 30, 2018 | 50.26M |
| June 30, 2018 | 55.32M |
| March 31, 2018 | 50.69M |
| December 31, 2017 | 11.52M |
| September 30, 2017 | 4.558M |
| June 30, 2017 | 9.334M |
| March 31, 2017 | 18.04M |
| December 31, 2016 | 25.23M |
| September 30, 2016 | 31.48M |
| June 30, 2016 | 37.29M |
| March 31, 2016 | 27.18M |
| December 31, 2015 | 31.13M |
| September 30, 2015 | 33.65M |
| June 30, 2015 | 11.15M |
| March 31, 2015 | 14.23M |
| December 31, 2014 | 18.01M |
| September 30, 2014 | -4.648M |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 0.7068M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 253.51M |
| Total Liabilities (Quarterly) | 36.64M |
| Debt to Equity Ratio | 0.1044 |
| Current Ratio | 21.18 |
| Net Debt Paydown Yield | -0.21% |